Skip to content

Author

M. Catalano

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Apalutamide in prostate cancer: clinical evidence, disease modification hypothesis, and emerging treatment de‑intensification strategies.

INTRODUCTION Apalutamide is a potent androgen receptor pathway inhibitor with established efficacy in non-metastatic castration-resistant and metastatic hormone-sensitive prostate cancer. Emerging evidence has also raised questions regarding the biological impact of early treatment, depth of response, and the potential...

M. Catalano, G. Roviello · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.